Topic

North Carolina

A collection of 445 issues

Renewing Turalio (Pexidartinib) Approval with Blue Cross Blue Shield in North Carolina: Complete Timeline and Documentation Guide

Answer Box: Renewing Turalio Approval in North Carolina Blue Cross Blue Shield of North Carolina requires annual prior authorization renewal for Turalio (pexidartinib), typically 30-60 days before your current approval expires. You'll need updated TGCT diagnosis confirmation, proof of REMS program compliance with current liver function tests, and

The Requirements Checklist to Get Cystadane (betaine anhydrous) Covered by UnitedHealthcare in North Carolina

Answer Box: Getting Cystadane Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Cystadane (betaine anhydrous) through OptumRx. You'll need genetic/biochemical confirmation of homocystinuria, documentation that vitamin B6/B12/folate therapy failed or is inappropriate, and specialist oversight. If denied, North Carolina offers external review

How to Get Emflaza (Deflazacort) Covered by Blue Cross Blue Shield of North Carolina: Complete Guide with Forms and Appeals

Answer Box: Getting Emflaza Covered in North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Emflaza (deflazacort) for Duchenne muscular dystrophy patients. The fastest path: 1) Have your doctor complete the Emflaza Prior Authorization Form with DMD genetic testing documentation, 2) Submit via the Blue e

How to Get Rinvoq (upadacitinib) Covered by Aetna CVS Health in North Carolina: Complete Guide with Forms and Appeals

Answer Box: Getting Rinvoq (upadacitinib) Covered by Aetna CVS Health in North Carolina Rinvoq requires prior authorization from Aetna CVS Health, with step therapy requiring failure of at least one TNF inhibitor biologic. Submit PA through Aetna's provider portal with diagnosis documentation, prior therapy records, and baseline labs.

How to Get Oxlumo (Lumasiran) Covered by Blue Cross Blue Shield in North Carolina: Appeals, Timelines & State Protections

Quick Answer: Getting Oxlumo Covered in North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Oxlumo (lumasiran) with specific PH1 documentation. If denied, you have strong state protections: expedited appeals within 72 hours for urgent cases, step therapy exceptions for medical necessity, and Smart NC external

How to Get Photrexa (Riboflavin) Covered by Blue Cross Blue Shield in North Carolina: Complete PA Guide and Appeal Timeline

Answer Box: Getting Photrexa Covered in North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Photrexa (riboflavin ophthalmic solution) used in corneal cross-linking for progressive keratoconus. To get approved: (1) Gather serial topography showing Kmax increase ≥1.0 diopter over 6-12 months, (2) Submit PA request

How Long Does It Take to Get Amvuttra (Vutrisiran) Approved by Blue Cross Blue Shield in North Carolina? Complete Timeline Guide

Answer Box: Amvuttra Approval Timeline in North Carolina Blue Cross Blue Shield of North Carolina processes Amvuttra (vutrisiran) prior authorization requests within 15 calendar days for standard submissions and 72 hours for urgent cases. The fastest path to approval requires complete documentation upfront: TTR genetic testing results, cardiomyopathy diagnosis confirmation,

How to Get Tremfya (Guselkumab) Covered by UnitedHealthcare in North Carolina: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Tremfya Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Tremfya (guselkumab) in North Carolina, with step therapy through TNF inhibitors typically required first. The fastest path to approval: 1) Gather documentation of failed TNF inhibitor trials and current disease severity (PASI scores for psoriasis)

How to Get Cerezyme (imiglucerase) Covered by UnitedHealthcare in North Carolina: Complete Appeals Guide with Forms and Timelines

Quick Answer: UnitedHealthcare covers Cerezyme (imiglucerase) for Type 1 Gaucher disease in North Carolina with prior authorization. You'll need confirmed diagnosis via enzyme assay and genetic testing, specialist oversight, and may face step therapy requiring trial of alternative ERTs first. If denied, use North Carolina's Smart

If Kuvan Isn't Approved by Blue Cross Blue Shield in North Carolina: Formulary Alternatives & Exception Paths

Answer Box: Your Options When Kuvan Is Denied If Blue Cross Blue Shield of North Carolina denies Kuvan (sapropterin), you have three main paths: try formulary alternatives like Palynziq or medical foods, request a formulary exception with comprehensive documentation, or appeal through Smart NC's external review. Start by